Massive study aims to crack code of rare brain aneurysm
NCT ID NCT06541106
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tracks 2,000 people in China with a rare brain aneurysm called a vertebrobasilar dissecting aneurysm (VBDA). Doctors will use different treatments—observation, stenting, or flow diverters—and follow patients to see which works best. The goal is to create clear guidelines for treating this condition and prevent strokes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors choose the best treatment for each patient with this rare brain aneurysm, reducing stroke risk and improving recovery.
- What could go wrong
- This is an observational registry, not a controlled trial, so it cannot prove one treatment is better. Results may take years and might not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DISSECTING ANEURYSM OF CEREBRAL ARTERY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Tiantan Hospital
RECRUITINGBeijing, Beijing Municipality, 100010, China